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Introduction
Arthropod-borne (arbo)viruses continue to pose a threat to human and animal health [1, 2] . In particular the order Bunyavirales comprises emerging pathogens such as Crimean-Congo haemorrhagic fever virus (CCHFV) and Rift Valley fever virus (RVFV) [3, 4] . The World Health Organization (WHO) has included both CCHFV and RVFV to the "Blueprint" list of ten prioritized viruses likely to cause future epidemics and for which insufficient countermeasures are available [5] . In the veterinary field, prioritized viral diseases of animals, including RVFV, are notifiable to the World Organization for Animal Health (Office International des Epizooties, OIE). Apart from pathogens that are recognised as major threats by WHO and OIE, many have remained largely neglected. Before the turn of the century, West Nile virus, chikungunya virus, and Zika virus were among these neglected viruses until they reminded us how fast arboviruses can spread in immunologically naïve populations [2] . Although these outbreaks came as a surprise, in hindsight, smaller outbreaks in previously unaffected areas could have been recognised as early warnings.
Shuni virus (SHUV; family Peribunyaviridae, genus Orthobunyavirus, Simbu serogroup) is a possible arbovirus that recently emerged in two very distant areas of the world [6] . SHUV was isolated for the first time from a slaughtered cow in the 1960s in Nigeria [7] . During subsequent years, the virus was isolated on several occasions from domestic animals including cattle, sheep, goats, and horses [7] [8] [9] [10] , from wild animals including crocodiles and rhinoceros [10] , and from field-collected Culicoides biting midges and mosquitoes [8, 11, 12] . More recently, SHUV was associated with malformed ruminants in Israel [13, 14] . Emergence of SHUV in areas outside Sub-Saharan Africa shows the potential of this virus to spread to new areas, and increases the risk for SHUV outbreaks in bordering territories such as Europe. Isolation of SHUV from a febrile child and detection of antibodies in 3.9% of serum samples from veterinarians in South Africa shows that SHUV can infect humans as well, although its ability to cause human disease is still uncertain [7, 15, 16] .
Proper risk assessments rely on accurate knowledge of disease transmission cycles. Arbovirus transmission cycles can only become established when competent vectors and susceptible hosts encounter under suitable climatic conditions. Although SHUV has been isolated from pools of field-collected Culicoides biting midges and mosquitoes [7, 11, 12] , the role of both insect groups as actual vectors remains to be confirmed. Detection of virus in field-collected insects is not sufficient to prove their ability to transmit the virus. Arboviruses need to overcome several barriers (i.e. midgut and salivary gland barriers) inside their vector, before they can be transmitted [17, 18] . In addition to virus isolation from field-collected vectors, laboratory studies are therefore needed to experimentally test the ability of vectors to become infected with, maintain, and successfully transmit arboviruses (i.e., vector competence) [19] . To gain insights into the potential of Culicoides biting midges and mosquitoes to function as vectors of SHUV, we studied the susceptibility of four main arbovirus vector species (Culicoides nubeculosus and C. sonorensis biting midges, and Culex pipiens pipiens and Aedes aegypti mosquitoes) for SHUV.
Methods

Cell culture
African green monkey kidney cells (Vero E6; ATCC CRL-1586) were cultured in Eagle's minimum essential medium (Gibco, Carlsbad, CA, United States) supplemented with 5% fetal bovine serum (FBS; Gibco), 1% non-essential amino acids (Gibco), 1% L-glutamine (Gibco), and 1% antibiotic/antimycotic (Gibco). Cells were cultured as monolayers and maintained at 37˚C with 5% CO 2 .
Vero E6 cells that were used in biting midge and mosquito infection experiments in the biosafety level 3 (BSL3) facility were cultured in Dulbecco's modified Eagle medium (Gibco) supplemented with 10% FBS, penicillin (100 U/ml; Sigma-Aldrich, Saint Louis, MO, United States), and streptomycin (100 μg/ml; Sigma-Aldrich). Prior to infections in the BSL3 facility, Vero E6 cells were seeded in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-buffered DMEM medium (HEPES-DMEM; Gibco) supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (100 μg/ml), fungizone (50 μg/ml; Invitrogen, Carlsbad, United States), and gentamycin (50 μg/ml; Gibco).
C6/36 cells (ATCC CRL-1660), derived from Aedes albopictus mosquitoes, were cultured in L15 medium (Sigma-Aldrich) supplemented with 10% FBS, 2% Tryptose Phosphate Broth (Gibco), 1% nonessential amino acids solution, and 1% antibiotic/antimycotic. Cells were cultured as monolayers and incubated at 28˚C in absence of CO 2 .
KC cells [20] , derived from embryos of colonized C. sonorensis biting midges, were cultured as monolayers in modified Schneider's Drosophila medium (Lonza, Basel, Switzerland) with 15% FBS and 1% antibiotic/antimycotic at 28˚C in absence of CO 2 .
Shuni virus
SHUV (strain An10107, P2 Vero, 1980) was kindly provided by the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA). The virus was originally isolated from the blood of a slaughtered cow in 1966 in Nigeria by inoculation of neonatal mice [21] . The P3 cell culture stock was generated by inoculation of Vero E6 cells at a multiplicity of infection (MOI) of 0.001. The supernatant was harvested at 6 days post inoculation, centrifuged, and stored in aliquots at -80˚C. The P4 stock was generated by inoculating Vero E6 cells at MOI 0.01 using the P3 stock. At this MOI, full cytopathic effect (CPE) was present at 3 days post infection. Virus titers were determined using endpoint dilution assays (EPDA) on Vero E6 cells [22] . Titers were calculated using the Spearman-Kärber algorithm and expressed as 50% tissue culture infective dose (TCID 50 ) [23, 24] .
Growth curves
Cells were seeded in T25 cell culture flasks at densities of 7.5 × 10 5 (Vero E6), 1.5 × 10 6 (C6/ 36) or 2.5 × 10 6 (KC cells) per flask in 10 ml complete medium. After overnight incubation, the flasks were inoculated with SHUV at an MOI of 0.01 (P4 stock). The MOI calculation for each cell line was based on the virus titer that was determined on Vero E6 cells. One hour after inoculation, the medium was removed and replaced with fresh medium. At time points 0 (sample taken directly after medium replacement), 24, 48 and 72 h post infection, 200 μl samples were taken and stored at -80˚C for later analysis. Virus titers were determined by EPDA using Vero E6 cells [22] . , and provided with 6% glucose solution ad libitum. Cow blood (Carus, Wageningen, The Netherlands) was provided through a Parafilm M membrane using the Hemotek PS5 feeding system (Discovery Workshops, Lancashire, United Kingdom) for egg production. The Culex pipiens pipiens colony was established in the laboratory from egg rafts collected in the field in The Netherlands during August 2016. Egg rafts were individually hatched in tubes. Pools of approximately 10 first instar larvae were identified to the biotype level using real-time PCR [26] . The colony was started by grouping larvae from 93 egg rafts identified as the pipiens biotype. Mosquitoes were maintained at 23˚C with 16:8 light:dark cycle and 60% relative humidity [27, 28] . Adult mosquitoes were kept in Bugdorm-1 rearing cages and maintained on 6% glucose solution ad libitum. Cow blood or chicken blood (Kemperkip, Uden, The Netherlands) was provided through a Parafilm M membrane using the Hemotek PS5 feeding system for egg production. Egg rafts were transferred to square larval holding trays (25 x 25 x 8 cm, Kartell) filled with tap water and two drops of Liquifry No. 1. Hatched larvae were fed with a 1:1:1 mixture of bovine liver powder, ground rabbit food, and ground koi food. Pupae were collected every 2 days and placed in Bugdorm-1 insect rearing cages.
Insect rearing
Aedes aegypti mosquitoes from the Rockefeller strain (Bayer AG, Monheim, Germany) were used in all experiments. The mosquito colony was maintained as described before [29] . In short, mosquitoes were maintained at 27˚C with 12:12 light:dark cycle and 70% relative humidity. Adult mosquitoes were kept in Bugdorm-1 rearing cages and maintained on 6% glucose solution ad libitum. Human blood (Sanquin Blood Supply Foundation, Nijmegen, The Netherlands) was provided through a Parafilm M membrane using the Hemotek PS5 feeding system for egg production. Eggs were transferred to transparent square larval holding trays (19 x 19 x 20 cm, Jokey), filled for approximately one-third with tap water and three drops of Liquifry No. 1. Hatched larvae were fed with Tetramin Baby fish food (Tetra). Larval trays were closed with fine-meshed netting, to allow adult mosquitoes to emerge inside larval trays. Twice a week, adults were aspirated from larval trays and collected in Bugdorm-1 insect rearing cages.
Feeding of biting midges and mosquitoes with SHUV infectious blood
Groups of adult C. nubeculosus (1-6 days old), C. sonorensis (1-11 days old), Cx. p. pipiens (4-20 days old), and Ae. aegypti (4-11 days old) were transferred to plastic buckets (diameter: 12.2 cm, height: 12.2 cm; Jokey) closed with netting before being taken to the BSL3 facility. Culex p. pipiens mosquitoes were kept on water for 3 days, whereas the other species were maintained on 6% glucose solution until being offered an infectious blood meal. SHUV P3 stock with a mean titer of 3.0 x 10 6 TCID 50 /ml was mixed 1:1 with cow blood. The used cow blood was tested negative for Schmallenberg virus (SBV) antibodies, to prevent cross-neutralisation with SHUV. The infectious blood meal was provided through Parafilm M membrane using the Hemotek PS5 feeding system, under dark conditions at 24˚C and 70% relative humidity. After 1 h, insects were anesthetized with 100% CO 2 and kept on a CO 2 -pad to select fully engorged females. For each species, five fully engorged females were directly stored at -80˚C for each replicate. These samples were used to determine the ingested amounts of SHUV for each species. All remaining and fully engorged females were placed back into buckets with a maximum group size of 110 individuals per species per bucket. All insects were provided with 6% glucose solution ad libitum. Culicoides sonorensis and Ae. aegypti were kept at 28˚C for 10 days, whereas C. nubeculosus and Cx. p. pipiens were kept at 25˚C for 10 days. These temperatures were selected for optimal replication of the virus, and to reflect differences in the natural environmental temperature for each species. Three replicates of C. nubeculosus (total N = 243), C. sonorensis (total N = 48), and Cx. p. pipiens (total N = 211) were carried out, and two replicates of Ae. aegypti (total N = 149). During each replicate, biting midges and mosquitoes were fed in parallel with the same infectious blood meal.
Intrathoracic injections of mosquitoes with SHUV
Adult female Cx. p. pipiens (3-9 days old) and Ae. aegypti (4-6 days old) mosquitoes were injected with SHUV into the thorax to investigate the role of mosquito barriers on dissemination of SHUV. Mosquitoes were anesthetized with 100% CO 2 and positioned on the CO 2 -pad. Female mosquitoes were intrathoracically injected with 69 nl of SHUV (P3 stock with a titer of 3.0 x 10 6 TCID 50 /ml) using a Drummond Nanoject II Auto-Nanoliter injector (Drummond Scientific, Broomall, Unites States). Injected Cx. p. pipiens were maintained at 25˚C and injected Ae. aegypti were maintained at 28˚C. Mosquitoes were incubated for 10 days at the respective temperatures, and had access to 6% glucose solution ad libitum. Injections were done during a single replicate for Cx. p. pipiens (N = 50) and Ae. aegypti (N = 50).
Infectivity assays
After 10 days of incubation at the respective incubation temperatures, samples from surviving biting midges and mosquitoes were collected. Biting midges were anesthetized with 100% CO 2 and transferred individually to 1.5 ml Safe-Seal micro tubes (Sarstedt, Nümbrecht, Germany) containing 0.5 mm zirconium beads (Next Advance, Averill Park, NY, United States). For a selection of C. nubeculosus (N = 77) and C. sonorensis (N = 30), heads were removed from bodies and separately stored in tubes. All samples were stored at -80˚C until further processing.
Mosquitoes were anesthetized with 100% CO 2 to remove legs and wings. Mosquito saliva was then collected by inserting the proboscis into a 200 μl yellow pipet tip (Greiner Bio-One) containing 5 μl of a 1:1 solution of 50% glucose solution and FBS. The saliva sample was transferred to a 1.5 ml micro tube containing 55 μl of fully supplemented HEPES-DMEM medium. Mosquito bodies were individually stored in 1.5 ml Safe-Seal micro tubes containing 0.5 mm zirconium beads.
Frozen biting midge and mosquito tissues were homogenized for 2 min at maximum speed in the Bullet Blender Storm (Next advance), centrifuged for 30 seconds at 14,500 rpm in the Eppendorf minispin plus (Eppendorf, Hamburg, Germany), and suspended in 100 μl of fully supplemented HEPES-DMEM medium. Samples were blended again for 2 min at maximum speed, and centrifuged for 2 min at 14,500 rpm. Mosquito saliva samples were thawed at RT and vortexed before further use. In total 30 μl of each body or saliva sample was inoculated on a monolayer of Vero E6 cells in a 96 wells plate. After 2-3 h the inoculum was removed and replaced by 100 μl of fully supplemented HEPES-DMEM medium. Wells were scored for virus induced CPE at 3 and 7 days post inoculation. Virus titers of infected biting midge bodies and heads, as well as mosquito bodies and saliva were determined with EPDA on Vero E6 cells [29] . Virus titers were determined using the Reed & Muench algorithm [30] .
Statistical analysis
Infection, dissemination, and transmission rates were calculated, respectively, by dividing the number of females with virus-containing body (infection), virus-containing head (dissemination), or virus-containing saliva (transmission) by the total number of females tested in the respective treatment, and multiplied by 100. Dissemination and transmission success was calculated by dividing the number of virus-positive head or saliva samples, respectively, by the number of virus-positive bodies, and multiplied by 100. Two biting midge samples of which only the head was virus-positive, but not the body, were excluded from further analysis.
Results
Efficient growth of SHUV in mammalian, mosquito, and midge cells
Mammalian, mosquito, and midge cells were inoculated with SHUV to gain insight into the replicative fitness of this virus and strain in different host cell types. The results show that SHUV is capable to produce progeny in all three cell types (Fig 1) . Of note, a strong CPE was observed in the Vero E6 cells upon infection whereas no CPE was observed in the insect cell lines.
Culicoides biting midges are highly susceptible to SHUV infection
To evaluate the susceptibility of two species of biting midges (C. nubeculosus and C. sonorensis) for SHUV, groups of individuals of both species were orally exposed to an infectious blood meal with a mean SHUV titer of 3.0 x 10 6 TCID 50 /ml. SHUV titers of ingested blood were determined for a selection of 10 fully engorged females for each species, that were directly stored at -80˚C after feeding. Both species ingested low titers of SHUV which were below the detection limit of the endpoint dilution assay, indicating that the estimated number of ingested infectious viral particles was below 10 3 TCID 50 /ml.
Infection rates were also determined after 10 days of incubation at temperatures of 25˚C (C. nubeculosus and Cx. p. pipiens) or 28˚C (C. sonorensis and Ae. aegypti; Fig 2) . Both biting midge species showed high infection rates of 44.4% for C. nubeculosus (N = 243), and 60.4% for C. sonorensis (N = 48; Fig 2A) . SHUV replicated to mean titers of 9.2 x 10 3 TCID 50 /ml in body samples of C. nubeculosus and 3.3 x 10 4 TCID 50 /ml in body samples of C. sonorensis ( Fig   2C) . For one replicate experiment, heads were separated from the bodies and tested for presence of SHUV to assess whether the virus successfully passed from the midgut to the haemocoel, indicative of dissemination throughout the body. Dissemination rates were 18.2% (14/77) for C. nubeculosus and 10.0% (3/30) for C. sonorensis. Dissemination success, defined as the percentage of virus-positive heads out of the total number of virus-positive body samples, was 29.8% (14/47) for C. nubeculosus and 13.6% (3/22) for C. sonorensis. In all virus-positive heads that induced CPE, SHUV titers were all below the detection limit of 10 3 TCID 50 /ml. Because only very low amounts of SHUV were detected in biting midge heads, the actual percentage of disseminated infections might be higher. Considering the relatively high infection rates observed in this study and the absence of a salivary glands barrier in biting midges as shown in previous studies [17, 31] , both C. nubeculosus and C. sonorensis can be considered highly competent vectors for SHUV.
Low susceptibility of mosquitoes to SHUV
SHUV was previously isolated from field-collected mosquitoes [8] . Therefore we determined vector competence for two mosquito species (Cx. p. pipiens and Ae. aegypti) which are important vectors for several arthropod-borne viruses [22, 27, 29] . Similar to the biting midges, SHUV titers of ingested blood were determined for a selection of 10 fully engorged female mosquitoes that were directly stored at -80˚C after feeding on an infectious blood meal with a SHUV titer of 3.0 x 10 6 TCID 50 /ml. Similar to results obtained with the biting midges, both mosquito species ingested low amounts of SHUV that were below the detection limit of 10 3 TCID 50 /ml of the endpoint dilution assay. No SHUV infection was observed in the Cx. p. pipiens mosquitoes (N = 211) following oral exposure, whereas infection rates of 2% were found for orally exposed Ae. aegypti mosquitoes (N = 149; Fig 2B) . SHUV replicated to mean titers of 8.5 x 10 3 TCID 50 /ml in body samples of Ae. aegypti (Fig 2D) , which was comparable to titers found in biting midges. No SHUV was detected in any of the saliva samples taken from either Cx. p. pipiens or Ae. aegypti. Thus, SHUV was able to successfully infect a small proportion of Ae. aegypti mosquitoes but not Cx. p. pipiens, and no evidence was found for transmission of SHUV by mosquitoes.
The very low infection rates of mosquitoes triggered further investigation into potential mosquito barriers against SHUV infection. To this end, Cx. p. pipiens and Ae. aegypti mosquitoes were intrathoracically injected with SHUV, to bypass the potential midgut barrier. Direct injection of SHUV into the thorax resulted in high infection rates of 68% for Cx. p. pipiens (N = 50), and 100% for Ae. aegypti (N = 50; Fig 3A) . Transmission rates of 32% (16/50) were found for Cx. p. pipiens and 8% (4/50) for Ae.aegypti. This corresponds to transmission success of 47.1% (16/34) for Cx. p. pipiens and 8% (4/50) for Ae. aegypti. Interestingly, although infection rates of Cx. p. pipiens were below 100%, the transmission success was relatively high. This indicates a relatively weaker salivary gland barrier in Cx. p. pipiens compared to Ae. aegypti mosquitoes which had 100% infection rate, but relatively low transmission success.
To gain more insight in replication of SHUV, virus titers were determined for virusinfected mosquito body and saliva samples. Titers of virus-infected Cx. p. pipiens body samples were almost all below the detection limit of 10 3 TCID 50 /ml of the endpoint dilution assay ( Fig   3C) . This indicates that even when SHUV is injected into the thorax, there is no productive virus replication. In contrast, we found mean titers of 1.1 x 10 5 TCID 50 /ml for virus-infected
Ae. aegypti body samples. This shows that SHUV is able to successfully replicate in Ae. aegypti when the midgut barrier is bypassed. In the majority of mosquito saliva samples, SHUV titers were below the detection limit of 10 3 TCID 50 /ml of the endpoint dilution assay (Fig 3D) .
Taken together, SHUV is able to disseminate in mosquitoes, but both the midgut and salivary glands form a barrier for SHUV.
Discussion
SHUV was previously isolated from field-collected pools of Culicoides biting midges and from mosquitoes, but their relative importance in SHUV transmission remained to be confirmed. Here, we show for the first time that SHUV is able to infect and replicate in biting midges as well as in mosquitoes, but only the biting midge species evaluated in the present study can be considered competent vectors. Both C. nubeculosus and C. sonorensis showed high infection rates of 44.4% and 60.4% when incubated for 10 days at 25˚C and 28˚C, respectively. The absence of a salivary gland barrier in biting midges [17, 31] , and evidence of successful dissemination of SHUV to the heads indicates that the biting midge species evaluated in the present study are competent vectors of SHUV. Importantly, the finding that two different biting midge species from European and American origin are highly competent vectors suggests that various species of Culicoides may function as vectors of SHUV.
SHUV infection and replication in biting midges seems more efficient compared to other biting midge-borne viruses such as SBV and Bluetongue virus (BTV), which generally result in infection rates up to 30% [31] [32] [33] [34] [35] . Both SBV and BTV have caused sudden and large-scale epizootics in Europe, with devastating consequences for the livestock sector [36, 37] . The relatively high SHUV transmission potential by biting midges and ongoing emergence of SHUV to areas outside Sub-Saharan Africa [13] , should therefore be interpreted as a warning for its epizootic potential.
In contrast to the high infection rates in biting midges, only few orally exposed Ae. aegypti mosquitoes became infected with SHUV during 10 days of incubation at 28˚C. In addition, no evidence of successful dissemination to the salivary glands was found. SHUV replication and dissemination (8%) was observed when the virus was directly injected into the thorax of Ae. aegypti mosquitoes. This indicates that both the midgut infection barrier and the salivary gland barrier prevent infection and subsequent transmission of SHUV by Ae. aegypti mosquitoes. None of the Cx. p. pipiens mosquitoes that were orally exposed to SHUV became infected during 10 days of incubation at 25˚C. Moreover, replication of SHUV was low in Cx. p. pipiens, because the virus was not able to replicate to high titers when it was directly injected into the thorax. However, a relatively high percentage of mosquito saliva samples contained SHUV. We therefore conclude that the midgut barrier is the main barrier that prevents infection of Cx. p. pipiens with SHUV. Considering our results obtained with both a tropical and temperate mosquito species, it seems unlikely that mosquito species play an important role in the SHUV transmission cycle. Our findings are in line with an earlier study on the closely-related SBV, which showed no evidence for involvement of mosquitoes in transmission, although SBV was able to infect Cx. pipiens mosquitoes [38] .
Recent outbreaks of SBV and BTV showed the tremendous impact of midge-borne viruses on animal health [36, 37] . Our study demonstrates highly efficient infection and dissemination of SHUV in two biting midge species (C. nubeculosus and C. sonorensis), which illustrates its potential for emergence. SHUV should therefore be considered as an important arbovirus which may emerge further internationally in the near future. Future studies should test vector competence of field-collected Culicoides species for SHUV, to more accurately predict the efficiency of SHUV transmission following a first introduction into currently free areas. In addition, we recommend the development of diagnostic assays and a vaccine. These actions are essential to be prepared for newly emerging arboviruses with zoonotic potential such as SHUV.
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